Fig. 6

In vivo assessment of the anti-tumor effect of MoSe₂ NUs treatment under NIR. a Illustration of the experimental procedure. b Photographic representations of tumors from tumor-bearing mice subjected to various treatment regimens. c, d Alterations in tumor volume c and tumor mass d within the tumor-bearing models of the specified groups. (n = 5, mean ± S.D.; ns, no significant; *P < 0.05; **P < 0.01; one-way ANOVA). e) Fluctuations in the body weight of tumor-bearing models undergoing different treatments. f, g Immunohistochemistry (IHC) analysis of xenografted tumor sections, showing immunostaining for TrxR1 (f), and TUNEL staining g in the indicated groups (n = 3). Scale bar: 50 µm (400 ×)